Oxford Nanopore (UK) Today
| ONT Stock | 144.80 2.80 1.97% |
Performance3 of 100
| Odds Of DistressLess than 19
|
Oxford Nanopore is trading at 144.80 as of the 31st of January 2025, a 1.97 percent increase since the beginning of the trading day. The stock's lowest day price was 140.6. Oxford Nanopore has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Oxford Nanopore is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 955.04 M outstanding shares. More on Oxford Nanopore Technologies
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Oxford Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Oxford Nanopore's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Oxford Nanopore or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO CoFounder | Gordon Sanghera | ||||
| Thematic Idea | Healthcare (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Oxford Nanopore's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Oxford Nanopore's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsOxford Nanopore can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Oxford Nanopore's financial leverage. It provides some insight into what part of Oxford Nanopore's total assets is financed by creditors.
| |||||
Oxford Nanopore Technologies (ONT) is traded on London Exchange in UK and employs 1,281 people. Oxford Nanopore is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oxford Nanopore's market, we take the total number of its shares issued and multiply it by Oxford Nanopore's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Oxford Nanopore Tech operates under Biotechnology sector and is part of Health Care industry. The entity has 955.04 M outstanding shares.
Oxford Nanopore generates negative cash flow from operations
Check Oxford Nanopore Probability Of Bankruptcy
Ownership AllocationOxford Nanopore owns a total of 955.04 Million outstanding shares. Oxford Nanopore has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Oxford Ownership Details
Oxford Nanopore Tech Risk Profiles
Although Oxford Nanopore's alpha and beta are two of the key measurements used to evaluate Oxford Nanopore's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.15 | |||
| Semi Deviation | 4.22 | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.23 |
Oxford Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Oxford Nanopore without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Oxford Nanopore Corporate Directors
| Tim Cowper | CFO Director | Profile | |
| James Willcocks | Chief Director | Profile | |
| Nicholas Keher | CFO Director | Profile | |
| Spike Willcocks | Chief Director | Profile |
Other Information on Investing in Oxford Stock
Oxford Nanopore financial ratios help investors to determine whether Oxford Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Nanopore security.